The Potential Role of Visfatin in Mediating Vascular Dysfunction and Hypertension

被引:1
|
作者
Ceron, Carla S. [1 ]
Luizon, Marcelo R. [2 ]
Palei, Ana C. [3 ,4 ]
机构
[1] Univ Fed Ouro Preto, Inst Exact & Biol Sci, Dept Biol Sci, Ouro Preto, MG, Brazil
[2] Univ Fed Minas Gerais, Inst Biol Sci, Dept Genet Ecol & Evolut, Belo Horizonte, MG, Brazil
[3] Univ Mississippi Med Ctr, Sch Med, Dept Surg, Jackson, MS USA
[4] Univ Mississippi Med Ctr, Sch Med, Dept Surg, 2500 North State St Jackson, Jackson 39216, MS USA
基金
美国国家卫生研究院;
关键词
NITRIC-OXIDE FORMATION; TYROSINE KINASE-1;
D O I
10.1097/FJC.0000000000001457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:347 / 349
页数:3
相关论文
共 50 条
  • [1] Vascular dysfunction: a Janus face of visfatin in diabetes?
    Teoh, Hwee
    Lovren, Fina
    Verma, Subodh
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (04): : 459 - 461
  • [2] The Role of Vascular Endothelial Dysfunction in Hypertension With Hearing Loss
    Hou, Yinjing
    Liu, Bo
    ANGIOLOGY, 2024,
  • [3] Dual Role of Interleukin 17 in Vascular Dysfunction and Hypertension
    Kumar, Meena
    Guzik, Tomasz
    Harrison, David
    CIRCULATION, 2008, 118 (18) : S440 - S440
  • [4] Potential roles of visfatin/NAMPT on endothelial dysfunction in preeclampsia and pathways underlying cardiac and vascular remodeling
    Ceron, Carla S.
    Pereira, Daniela A.
    Sandrim, Valeria C.
    Luizon, Marcelo R.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (01) : 10 - 12
  • [5] ENDOTHELIN - POTENTIAL ROLE IN HYPERTENSION AND VASCULAR HYPERTROPHY
    SCHIFFRIN, EL
    HYPERTENSION, 1995, 25 (06) : 1135 - 1143
  • [6] IS VISFATIN INVOLVED IN THE VASCULAR DYSFUNCTION ASSOCIATED WITH DIABESITY AND AGEING?
    Ramos-Gonzalez, M.
    Vallejo, S.
    Alvaro, S. H. -L.
    Alejandra, R.
    Ines, V.
    Elena, C.
    Romacho, T.
    Cerezo, J. G.
    Concepcion, P.
    Sanchez-Ferrer, C. F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 33 - 33
  • [7] Role of thioredoxin-interacting protein in mediating endothelial dysfunction in hypertension
    Wang, Ruiyu
    Guo, Yongzheng
    Li, Lingjiao
    Luo, Minghao
    Peng, Linqian
    Lv, Dingyi
    Cheng, Zhe
    Xue, Qian
    Wang, Liang
    Huang, Jing
    GENES & DISEASES, 2022, 9 (03) : 753 - 765
  • [8] Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction
    Sueta, Daisuke
    Suyama, Koichi
    Sueta, Aiko
    Tabata, Noriaki
    Yamashita, Takayoshi
    Tomiguchi, Mai
    Takeshita, Takashi
    Yamamoto-Ibusuki, Mutsuko
    Yamamoto, Eiichiro
    Izumiya, Yasuhiro
    Kaikita, Koichi
    Yamamoto, Yutaka
    Hokimoto, Seiji
    Iwase, Hirotaka
    Tsujita, Kenichi
    ATHEROSCLEROSIS, 2017, 260 : 116 - 120
  • [9] Role of Complement-Related Inflammation and Vascular Dysfunction in Hypertension
    Ruan, Cheng-Chao
    Gao, Ping-Jin
    HYPERTENSION, 2019, 73 (05) : 965 - 971
  • [10] Visfatin: the potential role in glucose metabolism
    Sumarac-Dumanovic, Mirjana
    Duntas, Leonidas
    Polovina, Snezana
    Micic, Dragan
    OBESITY AND METABOLISM-MILAN, 2009, 5 (3-4): : 139 - 144